Predict your next investment

Flywheel company logo
INTERNET | Internet Software & Services / Database Management

See what CB Insights has to offer

Founded Year



Series C | Alive

Total Raised


Last Raised

$22M | 2 mos ago

About Flywheel

Flywheel provides a research data platform that works with biomedical and imaging data that are managed at life sciences, clinical, and academic institutions globally. Flywheel provides a comprehensive research data solution with all the tools needed for curation, image processing, machine learning workflows, and secure collaboration.

Flywheel Headquarter Location

807 Broadway St. NE Suite 350

Minneapolis, Minnesota, 55413,

United States


Latest Flywheel News


Sep 17, 2021

飞轮融资2200万美元收购竞争对手 本文共1096个字,阅读需3分钟 In a large clinical trial, a pharmaceutical company might collect information from hundreds of patients. But there are several steps in between collecting that data and making it usable for research. Flywheel, a company helping automate these processes, raised $22 million in funding led by 8VC. It’s using a portion of the funds to acquire longstanding competitor Radiologics. Although the companies did not disclose the terms of the deal, Flywheel CEO Jim Olson said about half of the funds are for the acquisition, including equity, and the other half is to extend the combined company’s runway. googletag.cmd.push { googletag.display; }); Minneapolis-based Flywheel was started by two Stanford researchers six years ago. They were looking for a better way to manage growing and increasingly complex research datasets. Flywheel started with academic researchers as its customers, and has since added clinics and hospitals that have a research segment, and life sciences companies. “The main thing we learned is they all have the same problem,” Olson said: managing large databases and supporting research workflows. He said Flywheel helps save researchers time by helping them manage their data, especially imaging data. For example, across several clinical trial partners, there’s no standardized format to receive the data, even if it’s for the same trial. So Flywheel’s work is to normalize that data, going into metadata to make images searchable, or removing any identifying information. They also tag and group images, such as by tumor characteristics. Radiologics’ work is similar. The St. Louis-based company, which has been around for more than a decade, also processes medical imaging data. But it caters to different clients, with an open source software product, and some paid hospitals and clinics. It also has a slightly different background. Where Radiologics focused on oncology and radiomics, Flywheel has more of a background in neurobiological imaging. With the acquisition, Olson will continue as CEO of the combined company and Radiologics’ CEO, Dan Marcus, will become its chief scientific officer. “Together, we’re going to help speed the development of clinical trials, get to discovery faster, and reduce wasted time and resources along the way,” Marcus in a news release. “I’m thrilled that our combined company will continue to serve the research community through open source and enterprise informatics solutions.” Flywheel’s ultimate goal is to build out a broader life science platform, extending beyond its strengths in medical imaging, Olson said. It currently has one large pharma customer, and a total of 60 clients across both companies. Radiologics’ open source software also has more than 300 users. Photo: AndreyPopov, Getty Images Promoted Have clouds of uncertainty dissipated? Covid-19’s impact on medical professional liability. Coverys Promoted Digital medicine: Solving the mental health crisis Peter Hames, Big Health Co-Founder & CEO Have clouds of uncertainty dissipated? Covid-19’s impact on medical professional liability. Coverys Digital medicine: Solving the mental health crisis Through digital therapeutics, we have a once in a lifetime opportunity to reinvent how we develop and deliver medicine. Peter Hames, Big Health Co-Founder & CEO 在大型临床试验中,制药公司可能会从数百名患者那里收集信息。但是在收集数据和使其用于研究之间还有几个步骤。Flywheel,一家帮助自动化这些过程的公司,在8VC的领导下筹集了2200万美元的资金。它正在用一部分资金收购长期竞争对手放射学公司。尽管两家公司没有披露交易条款,但飞轮首席执行官吉姆·奥尔森(Jim Olson)表示,约一半的资金用于收购,包括股权,另一半用于扩大合并后公司的跑道。推{googletag.cmd.push{googletag.display;});位于明尼阿波利斯的飞轮是由两名斯坦福大学的研究人员在六年前启动的。他们正在寻找一种更好的方法来管理不断增长和日益复杂的研究数据集。飞轮最初以学术研究人员为客户,此后增加了有研究部门的诊所和医院,以及生命科学公司。奥尔森说:“我们学到的主要事情是,他们都有同样的问题:管理大型数据库和支持研究工作流。”他说,飞轮通过帮助研究人员管理数据,特别是成像数据,帮助他们节省时间。例如,在几个临床试验伙伴之间,没有标准的格式来接收数据,即使是针对同一试验。因此,Flywheel的工作是将这些数据规范化,进入元数据以使图像可搜索,或者删除任何识别信息。他们还标记和分组图像,如通过肿瘤特征。放射学家的工作也是类似的。这家总部位于圣路易斯的公司已经存在了十多年,也处理医学成像数据。但它通过开源软件产品和一些付费医院和诊所来迎合不同的客户。它也有一个稍微不同的背景。在放射学侧重于肿瘤学和放射组学的地方,飞轮在神经生物学成像方面有更多的背景。随着收购的进行,奥尔森将继续担任合并后公司的首席执行官,Radiologics的首席执行官丹·马库斯(Dan Marcus)将成为其首席科学官。马库斯在一份新闻稿中说:“我们将共同帮助加快临床试验的发展,更快地发现,并减少沿途浪费的时间和资源。”奥尔森说:“我很高兴我们合并后的公司将继续通过开源和企业信息学解决方案为研究社区服务。”飞轮的最终目标是建立一个更广泛的生命科学平台,超越其在医学成像方面的优势。它目前有一个大型制药客户,两家公司总共有60个客户。Radiologics的开源软件也有300多个用户。图片:安德烈耶波波夫,盖蒂图像公司推广不确定性的阴云消散了吗?新冠肺炎对医疗职业责任的影响。Coverys推广数字医学:解决精神健康危机彼得·哈姆斯,大健康联合创始人兼首席执行官,不确定性的阴云消散了吗?新冠肺炎对医疗职业责任的影响。覆盖数字医学:通过数字治疗来解决精神健康危机,我们有一生一次的机会来重塑我们开发和提供医学的方式。彼得·哈梅斯,大健康联合创始人兼首席执行官 以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Flywheel

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Flywheel is included in 3 Expert Collections, including Digital Health.


Digital Health

11,260 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.


Artificial Intelligence

7,895 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Clinical Trials Tech

317 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

Flywheel Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Flywheel Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.